Duke University
IV iron modestly improves HFrEF outcomes but misses prespecified endpoint: HEART-FID
In adults with HF with reduced ejection fraction and iron deficiency, ferric carboxymaltose modestly improved the endpoint of death, HF hospitalization and 6-minute walk distance but did not achieve the prespecified significance level.
Disentangling long COVID from fibromyalgia: Patients often feel ‘disrespected, ignored’
Distinguishing between long COVID and fibromyalgia has challenged health care providers across specialties, but rheumatologists may be positioned to clearly define both conditions and offer patients much-needed relief and respect.
Early delivery, low stillbirth rate seen with pregnancy-related liver disorder
Women with intrahepatic cholestasis of pregnancy delivered earlier and had a lower percentage of stillbirths compared with women without the liver disorder, researchers reported in the American Journal of Obstetrics & Gynecology.
Dean C. Taylor, MD, COL (ret) USA, installed as president of AOSSM
The American Orthopaedic Society for Sports Medicine has announced Dean C. Taylor, MD, COL (ret) USA, as president of the society for 2023 to 2024, according to a press release.
Overhaul of ‘calcified’ US organ transplant system can expand donor pool, save lives
Despite an expanded availability of donor hearts, there remains a shortage of available donor organs for people in need of transplantation, and many experts point to widespread inefficiencies with the U.S. organ transplant system.
Addressing why veterans may be vaccine hesitant, ways to build patient-provider trust
WASHINGTON — When discussing COVID-19 vaccination with veterans who do not trust the health system, it is important to listen and not argue with them, according to a presentation at the American Thoracic Society International Conference.
With heart transplant advances, a quest for ‘holy grail’ of tolerance, improved outcomes
Heart transplantation is considered standard therapy for patients with end-stage HF, and survival and the availability of donor hearts have continued to improve over time.
Ezetimibe did not increase diabetes risk in IMPROVE-IT substudy
Researchers observed no increased risk for new-onset diabetes among IMPROVE-IT participants assigned to ezetimibe plus statin therapy vs. statin monotherapy, according to a research letter.
Q&A: Current gynecologic oncology drug shortage a ‘public health crisis’
So far in 2023, there has been an overwhelming shortage of chemotherapy drugs, of which several specifically impact gynecologic oncology providers and patients.
Low likelihood for undergoing lung cancer screening after referral among Black veterans
Compared with white veterans, Black veterans had a reduced likelihood of carrying out a lung cancer screening referral, according to study results published in JAMA Network Open.